These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 38578704

  • 1. Highly Sensitized Candidates Remain at Risk for Microvascular Inflammation Even When Donor-specific Antibody Is Avoided: A Matched Cohort Study.
    Agrawal A, Balakrishnan S, Gandhi MJ, Alexander MP, Cornell L, Bentall AJ, Kukla A, Stegall M, Schinstock CA.
    Transplantation; 2024 Sep 01; 108(9):1986-1993. PubMed ID: 38578704
    [Abstract] [Full Text] [Related]

  • 2. Clinical Significance of Microvascular Inflammation in the Absence of Anti-HLA DSA in Kidney Transplantation.
    Parajuli S, Redfield RR, Garg N, Aziz F, Mohamed M, Astor BC, Zhong W, Djamali A, Mandelbrot DA.
    Transplantation; 2019 Jul 01; 103(7):1468-1476. PubMed ID: 30335696
    [Abstract] [Full Text] [Related]

  • 3. Molecular diagnosis of antibody-mediated rejection: Evaluating biopsy-based transcript diagnostics in the presence of donor-specific antibodies but without microvascular inflammation, a single-center descriptive analysis.
    Harmacek D, Weidmann L, Castrezana Lopez K, Schmid N, Korach R, Bortel N, von Moos S, Rho E, Helmchen B, Gaspert A, Schachtner T.
    Am J Transplant; 2024 Sep 01; 24(9):1652-1663. PubMed ID: 38548057
    [Abstract] [Full Text] [Related]

  • 4. Donor-derived cell-free DNA predicted allograft rejection and severe microvascular inflammation in kidney transplant recipients.
    Kim HD, Bae H, Kang H, Lee H, Eum SH, Yang CW, Choi YJ, Chung BH, Oh EJ.
    Front Immunol; 2024 Sep 01; 15():1433918. PubMed ID: 39044817
    [Abstract] [Full Text] [Related]

  • 5. Kidney Transplant With Low Levels of DSA or Low Positive B-Flow Crossmatch: An Underappreciated Option for Highly Sensitized Transplant Candidates.
    Schinstock CA, Gandhi M, Cheungpasitporn W, Mitema D, Prieto M, Dean P, Cornell L, Cosio F, Stegall M.
    Transplantation; 2017 Oct 01; 101(10):2429-2439. PubMed ID: 28009780
    [Abstract] [Full Text] [Related]

  • 6. Clinical Relevance of Posttransplant DSAs in Patients Receiving Desensitization for HLA-incompatible Kidney Transplantation.
    Vo AA, Aubert O, Haas M, Huang E, Zhang X, Choi J, Peng A, Najjar R, Sethi S, Ammerman N, Lim K, Jordan SC.
    Transplantation; 2019 Dec 01; 103(12):2666-2674. PubMed ID: 30883456
    [Abstract] [Full Text] [Related]

  • 7. Antibody-Mediated Rejection Due to Preexisting versus De Novo Donor-Specific Antibodies in Kidney Allograft Recipients.
    Aubert O, Loupy A, Hidalgo L, Duong van Huyen JP, Higgins S, Viglietti D, Jouven X, Glotz D, Legendre C, Lefaucheur C, Halloran PF.
    J Am Soc Nephrol; 2017 Jun 01; 28(6):1912-1923. PubMed ID: 28255002
    [Abstract] [Full Text] [Related]

  • 8. The clinical and genomic significance of donor-specific antibody-positive/C4d-negative and donor-specific antibody-negative/C4d-negative transplant glomerulopathy.
    Hayde N, Bao Y, Pullman J, Ye B, Calder RB, Chung M, Schwartz D, Lubetzky M, Ajaimy M, de Boccardo G, Akalin E.
    Clin J Am Soc Nephrol; 2013 Dec 01; 8(12):2141-8. PubMed ID: 24030736
    [Abstract] [Full Text] [Related]

  • 9. Clinical significance of low pre-transplant donor specific antibodies (DSA) in living donor kidney recipients with negative complement-dependent cytotoxicity crossmatches (CDCXM), and negative flow cytometry crossmatches (FLXM) - A single-center experience.
    Olszowska-Zaremba N, Gozdowska J, Zagożdżon R.
    Transpl Immunol; 2022 Oct 01; 74():101672. PubMed ID: 35868613
    [Abstract] [Full Text] [Related]

  • 10. Donor Specificity but Not Broadness of Sensitization Is Associated With Antibody-Mediated Rejection and Graft Loss in Renal Allograft Recipients.
    Wehmeier C, Hönger G, Cun H, Amico P, Hirt-Minkowski P, Georgalis A, Hopfer H, Dickenmann M, Steiger J, Schaub S.
    Am J Transplant; 2017 Aug 01; 17(8):2092-2102. PubMed ID: 28245084
    [Abstract] [Full Text] [Related]

  • 11. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
    Zheng J, Xue W, Qing X, Jing X, Hou J, Tian X, Guo Q, He X, Cai J.
    Clin Transpl; 2014 Aug 01; ():223-30. PubMed ID: 26281149
    [Abstract] [Full Text] [Related]

  • 12. C1q Donor-Specific Antibody Associates with Post-transplant Biopsy Findings in Highly- Sensitized Kidney Transplant Recipients.
    Kuppachi S, Holanda D, Gallegos S, Field EH.
    Clin Transpl; 2016 Aug 01; 32():127-134. PubMed ID: 28564530
    [Abstract] [Full Text] [Related]

  • 13. Molecular signatures and clinical outcomes of transplant glomerulopathy stratified by microvascular inflammation and donor-specific antibody.
    Lubetzky M, Hayde N, Ó Broin P, Ajaimy M, Bao Y, Mohammed O, Schwartz D, Pullman J, Akalin E.
    Clin Transplant; 2019 Mar 01; 33(3):e13469. PubMed ID: 30578675
    [Abstract] [Full Text] [Related]

  • 14. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
    Wu P, Jin J, Everly MJ, Lin C, Terasaki PI, Chen J.
    Clin Biochem; 2013 Oct 01; 46(15):1389-93. PubMed ID: 23726814
    [Abstract] [Full Text] [Related]

  • 15. An integrative approach for the assessment of peritubular capillaritis extent and score in low-grade microvascular inflammation-associations with transplant glomerulopathy and graft loss.
    Kozakowski N, Herkner H, Eskandary F, Eder M, Winnicki W, Kläger J, Bond G, Kikic Ž.
    Nephrol Dial Transplant; 2019 Jan 01; 34(1):166-174. PubMed ID: 30053273
    [Abstract] [Full Text] [Related]

  • 16. De novo donor specific antibodies and patient outcomes in renal transplantation.
    DeVos JM, Patel SJ, Burns KM, Dilioglou S, Gaber LW, Knight RJ, Gaber AO, Land GA.
    Clin Transpl; 2011 Jan 01; ():351-8. PubMed ID: 22755430
    [Abstract] [Full Text] [Related]

  • 17. Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen.
    Zecher D, Bach C, Staudner C, Böger CA, Bergler T, Banas B, Spriewald BM.
    Nephrol Dial Transplant; 2017 Apr 01; 32(4):730-737. PubMed ID: 28339671
    [Abstract] [Full Text] [Related]

  • 18. Impact of Donor Specific HLA Antibody Monitoring After Kidney Transplantation.
    Rao S, Ghanta M, Lee IJ, Gillespie A, Parekh HK, Geier SS, Zeng X, Karachristos A, Lau KN, Karhadkar S, Di Carlo A, Sifontis NM, Constantinescu S.
    Clin Transpl; 2014 Apr 01; ():143-51. PubMed ID: 26281139
    [Abstract] [Full Text] [Related]

  • 19. Clinical and pathological analyses of transplant glomerulopathy cases.
    Shimizu T, Ishida H, Toki D, Nozaki T, Omoto K, Tanabe K, Honda K, Koike J.
    Nephrology (Carlton); 2014 Jun 01; 19 Suppl 3():21-6. PubMed ID: 24842817
    [Abstract] [Full Text] [Related]

  • 20. Missing Self-Induced Microvascular Rejection of Kidney Allografts: A Population-Based Study.
    Callemeyn J, Senev A, Coemans M, Lerut E, Sprangers B, Kuypers D, Koenig A, Thaunat O, Emonds MP, Naesens M.
    J Am Soc Nephrol; 2021 Aug 01; 32(8):2070-2082. PubMed ID: 34301794
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.